CY1106375T1 - Χρηση της επιγαστινης για την αντιμετωπιση αλλepγικης ρινιτιδας/επιπεφυκιτιδας - Google Patents

Χρηση της επιγαστινης για την αντιμετωπιση αλλepγικης ρινιτιδας/επιπεφυκιτιδας

Info

Publication number
CY1106375T1
CY1106375T1 CY20071100351T CY071100351T CY1106375T1 CY 1106375 T1 CY1106375 T1 CY 1106375T1 CY 20071100351 T CY20071100351 T CY 20071100351T CY 071100351 T CY071100351 T CY 071100351T CY 1106375 T1 CY1106375 T1 CY 1106375T1
Authority
CY
Cyprus
Prior art keywords
epigastine
ependifuciitis
allepic
rhinitis
treatment
Prior art date
Application number
CY20071100351T
Other languages
English (en)
Inventor
Volker Trach
Gerold Duschler
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7928843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106375(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of CY1106375T1 publication Critical patent/CY1106375T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F01—MACHINES OR ENGINES IN GENERAL; ENGINE PLANTS IN GENERAL; STEAM ENGINES
    • F01L—CYCLICALLY OPERATING VALVES FOR MACHINES OR ENGINES
    • F01L9/00—Valve-gear or valve arrangements actuated non-mechanically
    • F01L9/20—Valve-gear or valve arrangements actuated non-mechanically by electric means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/0318—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)

Abstract

Η εφεύρεση αναφέρεται σε τοπικώς χορηγούμενα υδατικά διαλύματα που περιέχουν επιναστίνη, ενίοτε στη μορφή του ρακεμικού μείγματος αυτής, των εναντιομερών αυτής, καθώς και ενίοτε στη μορφή των φαρμακολογικά αποδεκτών αλάτων προσθήκης οξέος αυτής.
CY20071100351T 1999-11-12 2007-03-13 Χρηση της επιγαστινης για την αντιμετωπιση αλλepγικης ρινιτιδας/επιπεφυκιτιδας CY1106375T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19954516A DE19954516A1 (de) 1999-11-12 1999-11-12 Epinastin-haltige Lösungen
PCT/EP2000/010122 WO2001035962A1 (de) 1999-11-12 2000-10-14 Epinastin-haltige lösungen

Publications (1)

Publication Number Publication Date
CY1106375T1 true CY1106375T1 (el) 2011-10-12

Family

ID=7928843

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100351T CY1106375T1 (el) 1999-11-12 2007-03-13 Χρηση της επιγαστινης για την αντιμετωπιση αλλepγικης ρινιτιδας/επιπεφυκιτιδας

Country Status (40)

Country Link
US (6) US20030050303A1 (el)
EP (1) EP1231920B1 (el)
JP (1) JP2003514021A (el)
KR (1) KR100758842B1 (el)
CN (1) CN1292752C (el)
AR (1) AR026424A1 (el)
AT (1) ATE353218T1 (el)
AU (2) AU784017B2 (el)
BG (1) BG65775B1 (el)
BR (1) BR0015477A (el)
CA (1) CA2391076C (el)
CO (1) CO5251448A1 (el)
CY (1) CY1106375T1 (el)
CZ (1) CZ302483B6 (el)
DE (2) DE19954516A1 (el)
DK (1) DK1231920T3 (el)
EA (1) EA006937B1 (el)
EE (1) EE05395B1 (el)
ES (1) ES2281359T3 (el)
HK (1) HK1052303B (el)
HR (1) HRP20020404B1 (el)
HU (1) HU229502B1 (el)
IL (2) IL149501A0 (el)
ME (1) MEP36708A (el)
MX (1) MXPA02004556A (el)
MY (1) MY130441A (el)
NO (1) NO329417B1 (el)
NZ (1) NZ519425A (el)
PE (1) PE20010826A1 (el)
PL (1) PL198879B1 (el)
PT (1) PT1231920E (el)
RS (1) RS50173B (el)
SA (1) SA01210658B1 (el)
SI (1) SI1231920T1 (el)
SK (1) SK287343B6 (el)
TR (1) TR200201270T2 (el)
TW (1) TWI225401B (el)
UA (1) UA74563C2 (el)
WO (1) WO2001035962A1 (el)
ZA (1) ZA200203683B (el)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
CA2494065A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
EP1468696A1 (en) * 2003-04-17 2004-10-20 Boehringer Ingelheim International GmbH Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
EP1901724A1 (en) * 2005-07-08 2008-03-26 Senju Pharmaceutical Co., Ltd. Percutaneously absorptive ophthalmic preparation comprising epinastine
US7378082B1 (en) 2007-11-05 2008-05-27 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
US20080194544A1 (en) * 2007-02-08 2008-08-14 Ramesh Krishnamoorthy Aqueous formulations of epinastine for treating allergic rhinitis
WO2008098122A2 (en) * 2007-02-08 2008-08-14 Inspire Pharmaceuticals, Inc. Method for treating allergic rhinitis without adverse effects
EP2464387A4 (en) * 2009-08-12 2013-05-15 Seros Medical Llc DEUTERATED WATER SOLUTION AND RIBOFLAVIN FOR EXTENDED OXYGEN SINGULET LIFETIME IN THE TREATMENT OF OCULAR TISSUE AND METHOD OF USE
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
AU2013361579B2 (en) * 2012-12-19 2018-05-24 Bausch + Lomb Ireland Limited LFA-1 inhibitor formulations
CN104491876A (zh) * 2014-12-23 2015-04-08 中国药科大学 含玻璃酸钠的依匹斯汀滴眼液及其制备方法
ITUB20153950A1 (it) * 2015-09-28 2017-03-28 Tred Srl Dispositivo nasale in grado di attivare il riflesso rino-palatale per l'igienizzazione rinofaringea
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6635974B2 (ja) * 2017-04-24 2020-01-29 参天製薬株式会社 エピナスチン含有点眼液
KR102582048B1 (ko) * 2017-05-01 2023-09-21 산텐 세이야꾸 가부시키가이샤 점안제
JP6736752B2 (ja) * 2019-12-17 2020-08-05 参天製薬株式会社 エピナスチン含有点眼液
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP2020169213A (ja) * 2020-07-15 2020-10-15 参天製薬株式会社 エピナスチン含有点眼液
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US203021A (en) * 1878-04-30 Improvement in side-bar wagons
US8632A (en) * 1852-01-06 George hess
US151541A (en) * 1874-06-02 Improvement in hay-loaders
US104017A (en) * 1870-06-07 Improvement in embroidering attachment for sewing-machines
US228359A (en) * 1880-06-01 jones
US181478A (en) * 1876-08-22 Improvement in water-wheels
US215396A (en) * 1879-05-13 Improvement in loom-temples
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
US5668133A (en) * 1992-12-09 1997-09-16 Alcon Laboratories, Inc. Ophthalmic compositions comprising emedastine and methods for their use
DK0835098T3 (da) * 1995-06-27 2002-10-07 Boehringer Ingelheim Pharma Stabilt lægemiddelpræparat til frembringlese af drivgasfrie aerosoler
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
US6201011B1 (en) * 1996-08-30 2001-03-13 Kyoto Pharmaceutical Industries, Ltd. Therapeutic agent for allergic dermatitis
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20030215396A1 (en) * 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
EP1242090A4 (en) * 1999-11-18 2004-02-11 Alcon Inc USE OF AN H1 ANTAGONIST AND A SAFE STEROID IN THE TREATMENT OF EYE CONDITIONS
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
FR2803520B1 (fr) * 2000-01-12 2002-09-20 Ceva Sante Animale Procede pour augmenter la production d'oeufs et consolider la coquille des oeufs chez les volailles
US20020094345A1 (en) * 2000-10-06 2002-07-18 Sara Abelaira Pharmaceutical compositions containing epinastine and pseudoephedrine
US20020151541A1 (en) * 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
US20020137764A1 (en) * 2000-10-31 2002-09-26 Karin Drechsel Inhalable formulation of a solution containing a tiotropium salt
DE10119718A1 (de) * 2001-04-21 2002-10-31 Boehringer Ingelheim Pharma Verfahren zur kontinuierlichen Herstellung inhalierfähiger Arzneistoffe, Vorrichtung zur Durchführung des Verfahrens und nach diesem Verfahren hergestellter Arzneistoff
US7420602B2 (en) * 2001-05-29 2008-09-02 Samsung Semiconductor Israel R&D Center (Sirc) Cmos imager for cellular applications and methods of using such
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
EP1350512A1 (en) * 2002-04-03 2003-10-08 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
US6863848B2 (en) * 2002-08-30 2005-03-08 Signet Armorlite, Inc. Methods for preparing composite photochromic ophthalmic lenses
JP2007145316A (ja) * 2005-10-27 2007-06-14 Nissan Motor Co Ltd 遮光装置とサンバイザーとサンルーフユニット

Also Published As

Publication number Publication date
ES2281359T3 (es) 2007-10-01
YU33602A (sh) 2005-03-15
AU784017B2 (en) 2006-01-12
MEP36708A (en) 2011-02-10
BR0015477A (pt) 2002-06-25
US20090239842A1 (en) 2009-09-24
DE50014041D1 (de) 2007-03-22
HU229502B1 (en) 2014-01-28
AR026424A1 (es) 2003-02-12
IL149501A0 (en) 2002-11-10
US20080009476A1 (en) 2008-01-10
HRP20020404B1 (en) 2007-08-31
NZ519425A (en) 2004-04-30
KR100758842B1 (ko) 2007-09-19
SK8302002A3 (en) 2002-09-10
AU2006201541A1 (en) 2006-05-11
EP1231920A1 (de) 2002-08-21
CA2391076C (en) 2008-06-17
US20070185082A1 (en) 2007-08-09
NO329417B1 (no) 2010-10-18
HUP0203773A3 (en) 2005-01-28
MXPA02004556A (es) 2004-09-10
CA2391076A1 (en) 2001-05-25
PE20010826A1 (es) 2001-08-20
CZ302483B6 (cs) 2011-06-08
NO20022201D0 (no) 2002-05-08
TWI225401B (en) 2004-12-21
MY130441A (en) 2007-06-29
BG65775B1 (bg) 2009-11-30
EE05395B1 (et) 2011-04-15
PT1231920E (pt) 2007-03-30
EP1231920B1 (de) 2007-02-07
IL149501A (en) 2012-04-30
EA200200492A1 (ru) 2002-10-31
EA006937B1 (ru) 2006-06-30
US20070197503A1 (en) 2007-08-23
HK1052303A1 (en) 2003-09-11
CZ20021956A3 (cs) 2002-08-14
ATE353218T1 (de) 2007-02-15
PL198879B1 (pl) 2008-07-31
AU1138101A (en) 2001-05-30
ZA200203683B (en) 2003-09-03
SK287343B6 (sk) 2010-07-07
EE200200246A (et) 2003-06-16
HK1052303B (zh) 2007-04-13
HRP20020404A2 (en) 2004-08-31
HUP0203773A2 (hu) 2003-03-28
BG106681A (en) 2002-12-29
DE19954516A1 (de) 2001-05-17
PL364028A1 (en) 2004-11-29
KR20020050273A (ko) 2002-06-26
UA74563C2 (uk) 2006-01-16
CN1390129A (zh) 2003-01-08
US20050288274A1 (en) 2005-12-29
WO2001035962A1 (de) 2001-05-25
US20030050303A1 (en) 2003-03-13
US7429602B2 (en) 2008-09-30
SI1231920T1 (sl) 2007-06-30
NO20022201L (no) 2002-05-08
CN1292752C (zh) 2007-01-03
SA01210658B1 (ar) 2006-11-05
DK1231920T3 (da) 2007-04-10
CO5251448A1 (es) 2003-02-28
RS50173B (sr) 2009-05-06
JP2003514021A (ja) 2003-04-15
TR200201270T2 (tr) 2002-12-23

Similar Documents

Publication Publication Date Title
CY1106375T1 (el) Χρηση της επιγαστινης για την αντιμετωπιση αλλepγικης ρινιτιδας/επιπεφυκιτιδας
CY1114417T1 (el) Ετεροκυκλικες ενωσεις, δραστικες ως αναστολεις των βητα-λακταμασων
BR0014178A (pt) Derivados de ácido dicarboxìlico com propriedades farmacêuticas
CY1106674T1 (el) Αζαδικυκλικοι ετεροκυκλοι σαν ρυθμιστες υποδοχεα κανναβινοειδους
CY1106679T1 (el) Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα
CY1106801T1 (el) Νεες ετεροκυκλικες ενωσεις, η παρασκευη τους και η χρηση τους ως φαρμακα, ιδιαιτερα ως αντιβακτηριακα
CY1110104T1 (el) Παραγωγα της πιπεραζινης ως αναστολεις ταχυκινινων
CY1106598T1 (el) Παραγωγα κινολινης και ισοκινολινης, μεθοδος για την παραγωγη αυτων και χρηση αυτων ως αντιφλεγμονωδη μεσα
EE200100485A (et) Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
ECSP034460A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos
CY1112671T1 (el) Σταθερο πολυμορφο υδροχλωρικης ν-(3-αιθυνυλφαινυλαμινο)-6,7-δις(2-μεθοξυαιθοξυ)-4-κιναζολιναμινης, μεθοδοι παραγωγης, και φαρμακευτικες χρησεις αυτης
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
CY1110019T1 (el) Συνδυασμενη θεραπεια με υποκατεστημενες οξαζολιδινονες
IS8230A (is) Setið 2-amínótetralín til notkunar við meðferð á þunglyndi
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
TR199900486T2 (xx) Aziniloksi ve fenoksi-diaril-karbonasit t�revleri.
CY1105039T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΝΩΣΕΙΣ ΒΕΝΖΟ[b]ΑΖΕΠΙΝ-2-ΟΝΗΣ
CY1107825T1 (el) Εισπνεομενα σκευασματα τυπου διαλυματος με αλαστιοτροπιου
CY1105591T1 (el) Αναστολεις για συνθαση του 20-ηετε
NO975028L (no) Piperazinoderivater som neurokininantagonister
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
CY1105403T1 (el) Χρηση της ακετυλο-l-καρνιτινης σε συνδυασμο με τη βιοτινη για τη θepαπεια ασθενων με ινσουλινο-ανθεκτικο σακχαρωδη διαβητη τυπου 2
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их